Joseph Bergman, MD
Orthopaedic Surgery · Kalispell, MTNPI 1285898569
Payments from drug & device makers
What this record shows
Stryker accounts for 86.0% of it on its own, with 2 other manufacturers making up the rest. Reporting peaked in 2019 at $1,246 and has fallen 74.0% since, to $324 in 2024.
Across 23 payments — averaging $80.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$2K
- Medacta USA, Inc.$144
- Johnson & Johnson$113
What the payments were for
- Travel & lodging$77042%
- Food & beverage$1,07158%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 20 | $1,583 |
| Medacta USA, Inc. | 1 | $144 |
| Johnson & Johnson | 2 | $113 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MAKO$843
- GMK Sphere Revision System$144
- AXSOS$110
How this compares
$1,840 in reported general payments places this provider in the 55th percentile of 76 orthopaedic surgery providers in Montana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Meloxicam | 225 | $599 |
| Celecoxib | 29 | $290 |
| Diclofenac Sodium | 26 | $277 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Kalispell
- Benjamin WardKalispell$8K
- Karen PerserKalispell$7K
- Kim StimpsonKalispell$6K
- Scott RogersKalispell$6K
- Timothy JoyceKalispell$4K
- Stanley MakmanKalispell$3K
- Matthew BaileyKalispell$1K
- Mark MagillKalispell$980
- Brian DrakeBillings$84K
- Daniel WhitingMissoula$39K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.